ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

SP

STCube Pharmaceuticals at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

STCube Pharmaceuticals takes part in 3 sessions at ESMO 2026 in Madrid. Its work examines BTN1A1 in lung and colorectal cancers, including treatment resistance. One study evaluates nelmastobart with docetaxel in relapsed non-small-cell lung cancer expressing BTN1A1.

OrganizationESMO 2026 Attendance
SP
STCube Pharmaceuticals
Rockville, MD
Biotech
Biotechnology company developing cancer therapeutics.
Poster
Fri Oct 23
13:00–15:00
Cell DIVE profiling of BTN1A1-associated spatial TME phenotypes in refractory CRC
ePoster session 22
Gastrointestinal cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at STCube Pharmaceuticals

Tell us what you sell and we’ll find the people at STCube Pharmaceuticals most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction